Medicare Enrolled

Dr. Mel Strange, MD

Family Medicine · Hoquiam, WA
Low-engagement
815 K ST, Hoquiam, WA 98550
3605381609
In practice since 2006 (20 years)
NPI: 1144299603 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Strange from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Strange? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Strange

Dr. Mel Strange is a family medicine specialist in Hoquiam, WA, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Strange received a total of $9,551 from 44 pharmaceutical and/or device companies across 557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Strange is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $9,551 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$9,551
Total received (2018-2024)
Avg $1,364/year across 7 years
Top 3% in WA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
557
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,334 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$218 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,352
2023
$967
2022
$242
2021
$2,044
2020
$1,394
2019
$1,552
2018
$2,001

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$248
AstraZeneca Pharmaceuticals LP
$220
PFIZER INC.
$167
Lilly USA, LLC
$150
Novo Nordisk Inc
$146
GlaxoSmithKline, LLC.
$99
Bayer Healthcare Pharmaceuticals Inc.
$88
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
Novartis Pharmaceuticals Corporation
$63
Phathom Pharmaceuticals, Inc.
$40
Exact Sciences Corporation
$24
Abbott Laboratories
$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Top 3 companies account for 47.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,348
AstraZeneca Pharmaceuticals LP
$1,096
Lilly USA, LLC
$974
Novo Nordisk Inc
$898
PFIZER INC.
$743
Novartis Pharmaceuticals Corporation
$514
Boehringer Ingelheim Pharmaceuticals, Inc.
$488
GlaxoSmithKline, LLC.
$416
AbbVie Inc.
$357
SANOFI-AVENTIS U.S. LLC
$318
Janssen Pharmaceuticals, Inc
$316
Bayer Healthcare Pharmaceuticals Inc.
$261
Astellas Pharma US Inc
$176
Allergan Inc.
$138
Allergan, Inc.
$119
Mylan Specialty L.P.
$114
Amarin Pharma Inc.
$114
Bayer HealthCare Pharmaceuticals Inc.
$113
Kowa Pharmaceuticals America, Inc.
$113
Edwards Lifesciences Corporation
$103
Takeda Pharmaceuticals U.S.A., Inc.
$101
Sunovion Pharmaceuticals Inc.
$79
Merck Sharp & Dohme Corporation
$78
DEXCOM, INC.
$55
Esperion Therapeutics, Inc.
$43
ARBOR PHARMACEUTICALS, INC.
$42
Phathom Pharmaceuticals, Inc.
$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$38
Abbott Laboratories
$37
Biohaven Pharmaceuticals, Inc.
$36
E.R. Squibb & Sons, L.L.C.
$30
Dexcom, Inc.
$29
Seqirus USA Inc
$29
Otsuka America Pharmaceutical, Inc.
$27
Exact Sciences Corporation
$24
ITI, Inc.
$22
ABBVIE INC.
$20
Daiichi Sankyo Inc.
$20
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Gilead Sciences, Inc.
$14
Alkermes, Inc.
$13
SANOFI PASTEUR INC.
$13
Sanofi Pasteur Inc.
$12
Arbor Pharmaceuticals, Inc.
$11
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
ADACEL · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Afluria · Aimovig · BASAGLAR · BEXSERO · BREO · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · BROVANA · BYDUREON · CAPLYTA · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FASENRA · FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 3 · Horizant · INJECTAFER · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LOKELMA · LONHALA MAGNAIR · LYBALVI · LYRICA · LYUMJEV · Livalo · MOUNJARO · MYRBETRIQ · NEXLETOL · NURTEC ODT · Otezla · Ozempic · PAXLOVID · Ponvory · QULIPTA · RADICAVA · REXULTI · RYBELSUS · Repatha · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trintellix · UBRELVY · UTIBRON NEOHALER · Uloric · VOQUEZNA · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in WA.

Looking for a family medicine specialist in Hoquiam?
Compare family medicine physicians in the Hoquiam area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
22
Per 100K population
28.8
County median income
$63,539
Nearest hospital
GRAYS HARBOR COMMUNITY HOSPITAL
9.7 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Strange is a family medicine specialist, with low-engagement industry engagement in the top 3% of WA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Strange receive payments from pharmaceutical companies?
Yes. Dr. Strange received a total of $9,551 from 44 companies across 557 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Strange) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Hoquiam
Browse family medicine physicians in Hoquiam ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in WA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in WA
Which WA family medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →